Hematology Analyzers and Reagents Market by Products and Services, Price Range &; End User - 2023

The Hematology Analyzers and Reagents Market is projected to reach USD 5.0 billion by 2023 from USD 3.3 billion in 2018, at a CAGR of 8.5% during the forecast period. Factors such as the growth in blood donations, increasing incidence of blood disorder, and technological advancements in hematology analyzers and reagents are driving the growth of the market.


 The increasing incidence of blood disorders and the growth in blood donation are the major factors driving the growth of the global hematology products market. Furthermore, factors such as technological advancements in hematology analyzers and reagents and integration of flow cytometry techniques with hematology analyzers are expected to support the growth of this market during the forecast period.


Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146

The hematology products and services segment is expected to register the highest growth rate during the forecast period

On the basis of products & services, the hematology analyzers and reagents market is classified into hematology, hemostasis, and immunohematology products and services. The hematology products and services segment is projected to grow at the highest growth rate during the forecast period. Factors such as the increasing adoption of POC testing hematology analyzers in emerging economies, launch of technologically advanced hematology products coupled with the increasing preference towards automation, the growing trend of the ‘reagent rental’ business model, and the rising availability of a wide range of services from major hematology providers, are driving the growth of this segment.

Based on end user, the commercial service provider segment accounted for the largest share of the products and services market in 2017

By end user, the hematology products and services market is segmented into hospital laboratories, commercial service providers, government reference laboratories, and research & academic institutes. In 2017, the commercial service providers segment accounted for the largest share of the market due to the increasing awareness for hematology testing, shift from manual testing to automated testing, and competitive benefits offered by these providers as compared to hospitals (such as affordable service costs, efficient turnaround time, and efficient management for sample collection).

Read More :- https://www.marketsandmarkets.com/PressReleases/hematology-analyzers-reagents.asp 



The major players of the global hematology analyzers and reagents market are Sysmex (Japan), Danaher (US), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland).
 

 

In Vitro Diagnostics Market worth $87.93 Billion by 2023, at a CAGR of 5.2%

The In Vitro Diagnostics Market is projected to reach USD 87.93 billion by 2023 from USD 68.12 billion in 2018, at a CAGR of 5.2%.
Factors such as increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness on personalized medicine, increasing adoption of fully-automated instruments and automation in laboratories, and increasing adoption of point-of-care testing are driving the market growth.
Moreover, the introduction of a new range of condition-specific markers and tests, with advances in genomics and proteomics, is expected to offer significant growth opportunities for market players during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=703

In Vitro Diagnostics Market segmentation:

·         based on products

·         based on diseases

·         based on techniques,

·         based on application

·         based on end users

·         Based on regions.

The Major Players Opearting in the In Vitro Diagnostics Market:

The in vitro diagnostics market is highly competitive with several companies holding substantial market shares. The top five players in this market hold a share of ~55–60% in 2017. Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific (US) are the leading players in this market. Other players in this market are Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), Diasorin (Italy), Ortho-Clinical Diagnostics (US), and Qiagen (Germany). Major players in this market are continuously focusing on securing higher market shares through product launches, expansions, agreements, partnerships, collaborations, and acquisitions.

Geographical Detailed Analysis for In Vitro Diagnostics Market: The in vitro diagnostics market, by region, has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2017, North America dominates the market; and Asia Pacific is expected to witness the highest CAGR during the forecast period, owing to factors such as government efforts to increase awareness about the early detection of diseases and regular health check-ups; continuously rising healthcare expenditure; increasing number of hospitals and clinical diagnostic laboratories in India and China; and strengthening research base for diagnostic procedures across India, China, and Japan. Furthermore, the rapidly increasing geriatric population in Asian countries (particularly in Japan and China) and supportive government regulations will further aid the growth of this market during the forecast period.

Read More in Detailed (In Vitro Diagnostics Market):

https://www.marketsandmarkets.com/PressReleases/ivd-in-vitro-diagnostics.asp

Urinary Incontinence Segment to Dominate the Urinary Catheters Market

The report "Urinary Catheters Market by Product (Intermittent, Foley, Condom), Type (Coated, Uncoated), Indication (Urinary Incontinence, Benign Prostate Hyperplasia, Bladder Dysfunction, Spinal Cord Injury), Gender, End User - Global Forecast to 2022", The urinary catheters market is expected to reach USD 2.19 Billion by 2022 from USD 1.45 Billion in 2017, at a CAGR of 8.5% during the forecast period.

Further more information in details about Urinary Catheters Market Best Chance to increase growth in revenue of your company.

The growth in this market is mainly driven by the growing prevalence of urinary incontinence, increasing number of surgical procedures across the globe, and the favorable reimbursement scenario. The growing preference for single-use catheters and self-catheterization is a major trend that is expected to boost market growth in the coming years.



The urinary catheters market is highly competitive with the presence of major players. B. Braun Melsungen AG (Germany), Coloplast A/S (Denmark), C.R. Bard, Inc. (US), Hollister Incorporated (US), Medtronic plc (Ireland), Cook Medical (US), Teleflex Incorporation (US), and ConvaTec Group plc (UK) are the major companies operating in the urinary catheters market.